A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine

Схожие документы

• Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data
  по: Bejon, Philip, et al.
  Опубликовано: (2013)
• Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial
  по: White, Michael T, et al.
  Опубликовано: (2015)
• Peripheral blood monocyte-to-lymphocyte ratio at study enrollment predicts efficacy of the RTS,S malaria vaccine: analysis of pooled phase II clinical trial data
  по: Warimwe, George M, et al.
  Опубликовано: (2013)
• Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa
  по: Otieno, Lucas, et al.
  Опубликовано: (2020)
• The effect of immunization schedule with the malaria vaccine candidate RTS,S/AS01(E) on protective efficacy and anti-circumsporozoite protein antibody avidity in African infants
  по: Ajua, Anthony, et al.
  Опубликовано: (2015)